Wüstenberg, T <br/><br/>
Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia.  [electronic resource] 

 -  Molecular psychiatry  Jan 2011 
 - 26-36, 1 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5578 
<br/><br/><label>Standard No.: </label>10.1038/mp.2010.51  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Analysis of Variance<br/>Atrophy--drug therapy<br/>Attention--drug effects<br/>Brain--drug effects<br/>Double-Blind Method<br/>Erythropoietin--administration & dosage<br/>Humans<br/>Male<br/>Memory--drug effects<br/>Middle Aged<br/>Neuroprotective Agents--administration & dosage<br/>Recombinant Proteins<br/>Schizophrenia--drug therapy<br/>Treatment Outcome